Skip to main content
. 2021 Jun 14;11:12490. doi: 10.1038/s41598-021-92033-1

Table 1.

The clinico-epidemiological characteristics of the participants (n = 512,746).

Variable Number (%) Mean (SD)
Age, year 53.6 (9.6)
Sex, male 277,758 (54.2)
Residence at diagnosis
Seoul (capital city) 87,993 (17.2)
Other metropolitan city 140,239 (27.4)
Other area 284,514 (55.5)
Body mass index, kg/m2
18.5–24.9 (normal) 320,852 (62.6)
Below 18.5 (underweight) 11,860 (2.3)
25.0–29.9 (overweight) 164,840 (32.1)
Above 30.0 (obese) 14,717 (2.9)
Unknown 477 (0.1)
Annual income level
0–20% (lowest) 80,547 (15.7)
20–40% 69,896 (13.6)
40–60% 80,940 (15.8)
60–80% 107,981 (21.1)
80–100% (highest) 173,382 (33.8)
Underlying disability
Mild to moderate 2052 (0.4)
Severe 1245 (0.2)
Smoking status
Never smoker 331,264 (64.6)
Previous smoker 43,501 (8.5)
Current smoker 117,291 (22.9)
Unknown 20,690 (4.0)
Alcohol consumption
No drink 285,927 (55.8)
Mild drink group 89,244 (17.4)
Heavy drink group 125,752 (24.5)
Unknown 11,823 (2.3)
Exercise frequency
No exercise 285,668 (55.7)
1–2 per a week 118,117 (23.0)
3–4 per a week 47,073 (9.2)
5–6 per a week 13,170 (2.6)
Almost everyday 34,690 (6.8)
Unknown 14,028 (2.7)
Charlson comorbidity index 1.3 (1.6)
Family history of liver disease 15,459 (3.0)
Comorbid of mild liver disease 84,427 (16.5)
Comorbid of moderate to severe liver disease 1618 (0.3)
AST 26.9 (17.7)
Normal 383,050 (74.7)
Mild elevation 90,044 (17.6)
Moderate elevation 36,188 (7.1)
Severe elevation 3464 (0.7)
ALT 25.9 (21.0)
Normal 387,619 (75.6)
Mild elevation 65,905 (12.9)
Moderate elevation 54,435 (10.6)
Severe elevation 4787 (0.9)
AST/ALT ratio 1.2 (0.9)
dAAR − 0.04 (1.24)
γ-GTP 37.8 (54.4)
Normal 387,978 (75.7)
Mild elevation 82,824 (16.2)
Moderate elevation 21,080 (4.1)
Severe elevation 20,864 (4.1)

SD, standard deviation; AST, aspartate transaminase; ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase.